NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy
Intensive, combination chemotherapy for malignant diseases causes a profound immunosuppression, which persists for the whole treatment period and after its completion. Impairment of the NK cells status may increase the risk of severe, disseminated infections and cancer. The aim of the study was the...
Hauptverfasser: | Jarosz, M, Hak, L, Wieckiewicz, J, Balcerska, A, Mysliwska, J |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
Termedia Publishing House Ltd.
2009
|
Ähnliche Einträge
Ähnliche Einträge
-
Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
von: Amandeep Aujla, et al.
Veröffentlicht: (2019-04-01) -
Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
von: Ali Ghassemi, et al.
Veröffentlicht: (2016-06-01) -
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
von: Miguel Enrique Cuéllar Mendoza, et al.
Veröffentlicht: (2024-02-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
von: Betül Sevinir, et al.
Veröffentlicht: (2011-03-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
von: Betül Sevinir, et al.
Veröffentlicht: (2011-03-01)